Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Cancer J Clin. 2023;73(1):17–48.

Article  Google Scholar 

Waks AG, Winer EP. Breast Cancer Treatment: a review. JAMA. 2019;321(3):288–300.

Article  CAS  PubMed  Google Scholar 

Pondé NF, Zardavas D, Piccart M. Progress in adjuvant systemic therapy for breast cancer. Nat Reviews Clin Oncol. 2019;16(1):27–44.

Article  Google Scholar 

Lamballe F, Ahmad F, Vinik Y, Castellanet O, Daian F, Müller AK, Köhler UA, Bailly AL, Josselin E, Castellano R et al. Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2021;8(3):2003049.

Sobral-Leite M, Van de Vijver K, Michaut M, van der Linden R, Hooijer GKJ, Horlings HM, Severson TM, Mulligan AM, Weerasooriya N, Sanders J, et al. Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival. Oncoimmunology. 2018;7(12):e1509820.

Article  PubMed  PubMed Central  Google Scholar 

Denkert C, von Minckwitz G, Darb-Esfahani S, Lederer B, Heppner BI, Weber KE, Budczies J, Huober J, Klauschen F, Furlanetto J, et al. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 2018;19(1):40–50.

Article  PubMed  Google Scholar 

Gianni C, Palleschi M, Schepisi G, Casadei C, Bleve S, Merloni F, Sirico M, Sarti S, Cecconetto L, Di Menna G, et al. Circulating inflammatory cells in patients with metastatic breast cancer: implications for treatment. Front Oncol. 2022;12:882896.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tacconi F, Mangiameli G, Voulaz E, Patirelis A, Carlea F, Rocca E, Tamburrini A, Vanni G, Ambrogi V. Blood-derived systemic inflammation markers and risk of nodal failure in stage Ia Non-small Cell Lung Cancer: a multicentric study. J Clin Med 2023, 12(15).

So YK, Kim Z, Cheong TY, Chung MJ, Baek CH, Son YI, Seok J, Jung YS, Ahn MJ, Ahn YC et al. Detection of Cancer Recurrence using systemic inflammatory markers and machine learning after concurrent chemoradiotherapy for Head and Neck cancers. Cancers 2023, 15(14).

Savioli F, Morrow ES, Dolan RD, Romics L, Lannigan A, Edwards J, McMillan DC. Prognostic role of preoperative circulating systemic inflammatory response markers in primary breast cancer: meta-analysis. Br J Surg. 2022;109(12):1206–15.

Article  PubMed  Google Scholar 

Chen L, Bai P, Kong X, Huang S, Wang Z, Wang X, Fang Y, Wang J. Prognostic Nutritional Index (PNI) in patients with breast Cancer treated with Neoadjuvant Chemotherapy as a useful Prognostic Indicator. Front cell Dev Biology. 2021;9:656741.

Article  Google Scholar 

Takada K, Takamori S, Yoneshima Y, Tanaka K, Okamoto I, Shimokawa M, Oba T, Osoegawa A, Tagawa T, Takenoyama M, et al. Serum markers associated with treatment response and survival in non-small cell lung cancer patients treated with anti-PD-1 therapy. Lung cancer (Amsterdam Netherlands). 2020;145:18–26.

Article  PubMed  Google Scholar 

Stares M, Swan A, Cumming K, Ding TE, Leach J, Stratton C, Thomson F, Barrie C, MacLennan K, Campbell S, et al. Hypoalbuminaemia as a Prognostic Biomarker of First-Line Treatment Resistance in Metastatic Non-small Cell Lung Cancer. Front Nutr. 2021;8:734735.

Article  PubMed  PubMed Central  Google Scholar 

Liu X, Meng QH, Ye Y, Hildebrandt MA, Gu J, Wu X. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer. Carcinogenesis. 2015;36(2):243–8.

Article  PubMed  Google Scholar 

Peng P, Chen L, Shen Q, Xu Z, Ding X. Prognostic Nutritional Index (PNI) and Controlling Nutritional Status (CONUT) score for predicting outcomes of breast cancer: a systematic review and meta-analysis. Pakistan J Med Sci. 2023;39(5):1535–41.

Google Scholar 

Chen XL, Xue L, Wang W, Chen HN, Zhang WH, Liu K, Chen XZ, Yang K, Zhang B, Chen ZX, et al. Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study. Oncotarget. 2015;6(38):41370–82.

Article  PubMed  PubMed Central  Google Scholar 

Shi Y, Shen G, Zeng Y, Ju M, Chen X, He C, Liang L, Ge X, Sun X, Di X. Predictive values of the hemoglobin, albumin, lymphocyte and platelet score (HALP) and the modified -Gustave Roussy immune score for esophageal squamous cell carcinoma patients undergoing concurrent chemoradiotherapy. Int Immunopharmacol. 2023;123:110773.

Article  CAS  PubMed  Google Scholar 

Zhao R, Liang Z, Chen K, Zhu X. Nomogram based on Hemoglobin, Albumin, lymphocyte and platelet score to predict overall survival in patients with T3-4N0-1 nasopharyngeal carcinoma. J Inflamm Res. 2023;16:1995–2006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Toshida K, Itoh S, Kayashima H, Nagao Y, Yoshiya S, Tomino T, Fujimoto YK, Tsutsui Y, Nakayama Y, Harada N, et al. The hemoglobin, albumin, lymphocyte, and platelet score is a prognostic factor for child-pugh A patients undergoing curative hepatic resection for single and small hepatocellular carcinoma. Hepatol Research: Official J Japan Soc Hepatol. 2023;53(6):522–30.

Article  CAS  Google Scholar 

Kobayashi K, Goel A, Coelho MP, Medina Perez M, Klumpp M, Tewari SO, Appleton-Figueira T, Pinter DJ, Shapiro O, Jawed M. Complications of Ileal conduits after Radical Cystectomy: Interventional Radiologic Management. Radiographics: Rev Publication Radiological Soc North Am Inc. 2021;41(1):249–67.

Article  Google Scholar 

Jiang H, Li H, Li A, Tang E, Xu D, Chen Y, Zhang Y, Tang M, Zhang Z, Deng X, et al. Preoperative combined hemoglobin, albumin, lymphocyte and platelet levels predict survival in patients with locally advanced colorectal cancer. Oncotarget. 2016;7(44):72076–83.

Article  PubMed  PubMed Central  Google Scholar 

Lanehart RE, Gil PRd, Kim ES, Bellara AP, Lee R. Propensity score analysis and assessment of propensity score approaches using SAS ® procedures. In: 2012; 2012.

Yahoo N, Dudek M, Knolle P, Heikenwälder M. Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation. J Hepatol. 2023;79(2):538–51.

Article  CAS  PubMed  Google Scholar 

Yeaton A, Cayanan G, Loghavi S, Dolgalev I, Leddin EM, Loo CE, Torabifard H, Nicolet D, Wang J, Corrigan K, et al. The impact of inflammation-Induced Tumor Plasticity during Myeloid Transformation. Cancer Discov. 2022;12(10):2392–413.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.

Article  CAS  PubMed  Google Scholar 

Rothwell PM, Cook NR, Gaziano JM, Price JF, Belch JFF, Roncaglioni MC, Morimoto T, Mehta Z. Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials. Lancet (London England). 2018;392(10145):387–99.

Article  CAS  PubMed  Google Scholar 

Denk D, Greten FR. Inflammation: the incubator of the tumor microenvironment. Trends cancer. 2022;8(11):901–14.

Article  CAS  PubMed  Google Scholar 

Ouyang H, Xiao B, Huang Y, Wang Z. Baseline and early changes in the neutrophil-lymphocyte ratio (NLR) predict survival outcomes in advanced colorectal cancer patients treated with immunotherapy. Int Immunopharmacol. 2023;123:110703.

Article  CAS  PubMed  Google Scholar 

Liu W, Ren S, Yang L, Xiao Y, Zeng C, Chen C, Wu F, Hu Y. The predictive role of hematologic markers in resectable nsclc patients treated with neoadjuvant chemoimmunotherapy: a retrospective cohort study. Int J Surg (London England) 2023.

Dong H, Huang Z, Yang D, Li Z, Huang H, Meng Z, Qin Y, Kang M. Prognostic value of EBV DNA and platelet-to-lymphocyte ratio in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study. BMC Cancer. 2023;23(1):673.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Güç ZG, Alacacıoğlu A, Kalender ME, Oflazoğlu U, Ünal S, Yıldız Y, Salman T, Küçükzeybek Y, Tarhan MO. HALP score and GNRI: simple and easily accessible indexes for predicting prognosis in advanced stage NSCLC patients. The İzmir oncology group (IZOG) study. Front Nutr. 2022;9:905292.

Article  PubMed  PubMed Central  Google Scholar 

Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–503.

Article  PubMed  Google Scholar 

Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001;91(12):2214–21.

Article  CAS  PubMed  Google Scholar 

Belcher DA, Ju JA, Baek JH, Yalamanoglu A, Buehler PW, Gilkes DM, Palmer AF. The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: a theoretical and experimental study. PLoS ONE. 2018;13(2):e0191275.

Article  PubMed  PubMed Central  Google Scholar